Home Biotechnology Industry News Savara Pharmaceuticals’ AeroVanc for Cystic Fibrosis Patients Achieves…

Savara Pharmaceuticals’ AeroVanc for Cystic Fibrosis Patients Achieves…

Savara Pharmaceuticals’ AeroVanc for cystic fibrosis patients achieves positive results in Phase I clinical trial.

(PRWeb April 26, 2012)

Read the full story at http://www.prweb.com/releases/2012/4/prweb9444575.htm